One of the CT mAbs (5E6) demonstrates equivalent sensitivity in immunohistochemistry based detection of ovarian cancer cases as compared to tandem repeat epitope recognizing mAb (CA125). This evidence concerns the gene MUC16 and ovarian carcinoma.